Check SSc-ILD Patients on Ofev for Malnutrition, Study Suggests

(MedPage Today) -- During nintedanib (Ofev) treatment for interstitial lung disease associated with systemic sclerosis (SSc-ILD), clinicians prescribing the drug should be watchful for an unusual, indirect side effect, trial data suggested. Among...
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news